Xiao-Qian Xu (Xiaoqian Xu)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Cervical Cancer Screening

Top Venues

International journal of cancer

Human vaccines & immunotherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Tian-Meng Wen, Xiao-Qian Xu, Xue-Lian Zhao, Cheng-Hao Pan, Yu-Shu Feng, Ting-Ting You, Meng Gao, Shang-Ying Hu, Fang-Hui Zhao
Efficacy and immunogenicity of AS04-HPV-16/18 vaccine in females with existing cervical HR-HPV infection at first vaccination: A pooled analysis of four large clinical trials worldwide. International journal of cancer (2024)
Tian-Meng Wen, Xiao-Qian Xu, Xue-Lian Zhao, Cheng-Hao Pan, Yu-Shu Feng, Ting-Ting You, Meng Gao, Shang-Ying Hu, Fang-Hui Zhao
Efficacy and immunogenicity of AS04-HPV-16/18 vaccine in females with existing cervical HR-HPV infection at first vaccination: A pooled analysis of four large clinical trials worldwide. International journal of cancer 154 (12) (2024)
Tian-Meng Wen, Xiao-Qian Xu, Xue-Lian Zhao, Cheng-Hao Pan, Yu-Shu Feng, Ting-Ting You, Meng Gao, Shang-Ying Hu, Fang-Hui Zhao
Efficacy and immunogenicity of AS04-HPV-16/18 vaccine in females with existing cervical HR-HPV infection at first vaccination: A pooled analysis of four large clinical trials worldwide. International journal of cancer 154 (12) (2024)
Tian-Meng Wen, Xiao-Qian Xu, Xue-Lian Zhao, Cheng-Hao Pan, Yu-Shu Feng, Ting-Ting You, Meng Gao, Shang-Ying Hu, Fang-Hui Zhao
Efficacy and immunogenicity of AS04-HPV-16/18 vaccine in females with existing cervical HR-HPV infection at first vaccination: A pooled analysis of four large clinical trials worldwide. International journal of cancer 154 (12) (2024)
Shang-Ying Hu, Xiao-Qian Xu, Fengcai Zhu, Ying Hong, Yuemei Hu, Xun Zhang, Qinjing Pan, Wenhua Zhang, Chengfu Zhang, Xiaoping Yang, Jiaxi Yu, Jiahong Zhu, Yejiang Zhu, Feng Chen, Shuang Zhao, Naveen Karkada, Haiwen Tang, Dan Bi, Frank Struyf, Fanghui Zhao
Efficacy of the AS04-adjuvanted HPV-16/18 vaccine in young Chinese women with oncogenic HPV infection at baseline: post-hoc analysis of a randomized controlled trial. Human vaccines & immunotherapeutics 17 (4) (2020)